|
|
||||||||
1 Disease Cell Biology and
2 Cardiovascular Systems Units, GlaxoWellcome Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, England; and
3 Department of Orthopaedics, University of Aberdeen Medical School, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB9 2ZD, Scotland
Destruction of bone tissue due to disease and inefficient bone healing after traumatic injury may be addressed by tissue engineering techniques. Growth factor, cytokine protein, and gene therapies will be developed, which, in conjunction with suitable carriers, will regenerate missing bone or help in cases of defective healing.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |